These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20354817)

  • 1. The value of COX-2 expression in the prognostic parameters of invasive ductal carcinoma of the breast.
    Barısık NO; Keser SH; Gul AE; Sensu S; Kandemir NO; Kucuk HF; Gumus M; Karadayı N
    Med Oncol; 2011 Sep; 28(3):703-8. PubMed ID: 20354817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group.
    Ahmed SS; Thike AA; Zhang K; Lim JC; Tan PH
    J Clin Pathol; 2017 Apr; 70(4):320-326. PubMed ID: 27612503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
    Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
    Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma.
    Erdem O; Dursun A; Coşkun U; Günel N
    Tumori; 2005; 91(1):46-52. PubMed ID: 15850004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
    Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
    Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ErbB-2 expression and hormone receptor status in areas of transition from in situ to invasive ductal breast carcinoma].
    Peres RM; Derchain SF; Heinrich JK; Serra KP; Pinto GA; Soares FA; Sarian LO
    Rev Bras Ginecol Obstet; 2009 Sep; 31(9):461-7. PubMed ID: 19876578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast.
    Buhmeida A; Dallol A; Merdad A; Al-Maghrabi J; Gari MA; Abu-Elmagd MM; Chaudhary AG; Abuzenadah AM; Nedjadi T; Ermiah E; Al-Thubaity F; Al-Qahtani MH
    Tumour Biol; 2014 Mar; 35(3):2817-24. PubMed ID: 24248542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of astrocyte elevated gene-1, basic-fibroblast growth factor, beta-catenin, Ki-67, tumor necrosis factor-alfa with prognostic parameters in ductal carcinomas and ductal intraepithelial neoplasms.
    Erdem H; Gundogdu B; Ankarali H; Yasar M; Sener E; Oktay M; Bahadir A; Uzunlar AK; Gursan N; Ozaydin I; Sahiner C
    Niger J Clin Pract; 2015; 18(5):638-43. PubMed ID: 26096243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-erbB-2 and the "triple-state" in early breast carcinomas.
    Sivridis E; Stamos C; Fiska A; Nikolettos N; Koukourakis MI; Giatromanolaki A
    Med Oncol; 2010 Sep; 27(3):578-84. PubMed ID: 19548127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual predictive value of c-erbB-2 overexpression and various prognostic factors in ductal invasive breast carcinoma.
    Jakić-Razumović J; Petrovecki M; Uzarević B; Gamulin S
    Tumori; 2000; 86(1):30-6. PubMed ID: 10778763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
    Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
    Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of c-erbB-2 correlates with nuclear morphometry and prognosis in breast carcinoma in Asian women.
    Selvarajan S; Wong KY; Khoo KS; Bay BH; Tan PH
    Pathology; 2006 Dec; 38(6):528-33. PubMed ID: 17393979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of CK5/6 and CK17 and its correlation with prognosis of triple-negative breast cancer patients].
    Liu ZB; Wu J; Ping B; Feng LQ; Shen ZZ; Shao ZM
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):610-4. PubMed ID: 19102940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients.
    Haroon S; Hashmi AA; Khurshid A; Kanpurwala MA; Mujtuba S; Malik B; Faridi N
    Asian Pac J Cancer Prev; 2013; 14(7):4353-8. PubMed ID: 23992002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cell-cycle regulatory proteins BUBR1, MAD2, Aurora A, cyclin A and cyclin E in invasive ductal breast carcinomas.
    Du J; Du Q; Zhang Y; Sajdik C; Ruan Y; Tian XX; Fang WG
    Histol Histopathol; 2011 Jun; 26(6):761-8. PubMed ID: 21472690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of β-catenin in invasive ductal breast carcinomas.
    Abd El-Rehim D; Ali MM
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):185-95. PubMed ID: 21057570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological grade, p53, HER2 and hormone receptor status of synchronous bilateral breast carcinoma.
    Matsuo K; Fukutomi T; Akashi-Tanaka S; Hasegawa T; Tsuda H
    Breast Cancer; 2002; 9(2):127-33. PubMed ID: 12016392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients.
    Singh K; Wang Y; Marketkar S; Kalife ET; Steinhoff MM
    Hum Pathol; 2017 Jul; 65():123-132. PubMed ID: 28457730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.